Muscle defect studied in UK

Share on facebook
Share on twitter
Share on email

UK’s National Health Service collaboration between university and hospitals will hopefully trial drugs for muscle abnormality
Patients in the United Kingdom’s north east could benefit from research put into action.
Professor Julia Newton, Clinical Professor of Ageing and Medicine at Newcastle University, who also works within Newcastle upon Tyne Hospitals National Health Service (NHS) Foundation Trust, led a team who found an abnormality of a protein which could lead to the development of new drugs and treatments.
Researchers have found for the first time that patients with the condition have a defect in a molecule associated with the production of a protein known as AMP kinase (AMPK).
“Our study focused on whether there were any biochemical changes so that we can start to understand what happens in the muscle with fatigue,” Professor Newton said.  The study looked at 20 Fukuda-definition patients and 20 controls.
“What we have been able to identify is that production of AMPK is impaired in patients with CFS compared to those without. This is an important finding because there are drugs that are currently already available that we know will modify this abnormality. The next step is to carry out experiments to see whether or not we can reverse changes in AMPK with drugs that might ultimately form the basis of clinical trials…this is an exciting step towards that holy grail of trialling medicinal products,” Professor Newton said.
The new partnership brings together Newcastle Hospitals and Northumberland, Tyne and Wear NHS Foundation Trusts with Newcastle University, the newly-formed ‘Newcastle Academic Health Partners’  will deliver healthcare through collaborative scientific research, education and patient care.
“A real strength in the North East is that the University and hospital trusts work closely together, pulling on each other’s academic and clinical strengths so that we can be sure our work is of the very highest quality to help patients,” added Professor Newton.
Click here for more information on the partnership.

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

1 thought on “Muscle defect studied in UK”

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Covid-19 has worsened our ME, report survey respondents

Read the first findings from the survey #MEAction UK and #MEAction Scotland are conducting with Action for ME to gather evidence of the impact of Covid-19 on people with ME. Preliminary Report The aim of the survey is to provide data that can be used, along with personal stories, to help our campaign to make

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top